EUVIMEDEUVIMED entdecken
Crossref

Copper-doped layered double hydroxides co-deliver proteins/drugs for cascaded chemodynamic/immunotherapy via dual regulation of tumor metabolism

Gaoming Li, Zhiqiang Wang, Yunqi Guo, Cheng Ni, Yue Gao, Kaibing Xu, Tingting Xiao, Xiangyang Shi, Mingwu Shen

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2025.02.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Gaoming Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Fiber Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Bio…. Hauptthemen laut MEDLINE: Copper, Hydroxides, Immunotherapy, Drug Delivery Systems. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report here a Cu2+-doped layered double hydroxide (LDH) nanoplatform to load both monocarboxylate transporter inhibitor diclofenac (DC) and lactate oxidase (LOX) for dual modulation of tumor lactate and redox metabolisms to activate immunotherapy through enhanced Cu-mediated chemodynamic therapy (CDT) of tumors. The formed LDH-DC-LOX nanoparticles with a diameter of 55 nm are stable, can be effectively taken up by cancer cells to regulate lactate through both LOX-mediated catalytic conversion and DC-enabled inhibition of extracellular efflux of lactate, and can exert redox metabolism through CDT via Cu2+-mediated glutathione (GSH) depletion and Fenton-like reaction with hydrogen peroxide (H2O2) that can be further accumulated via LOX-mediated catalysis. The major advantage of the developed LDH-DC-LOX nanoparticles lies in the therapeutic synergy and cascade that can be achieved through the loaded DC and LOX for enhanced tumor lactate metabolism regulation, for enhanced Cu-mediated CDT and redox metabolism regulation, and for activation of immunotherapy that can further enhances the Cu2+-mediated CDT effect. The developed LDH nanoplatform demonstrated here for effective murine breast tumor treatment provides a new paradigm for dual regulation of lactate and redox metabolisms that may enable synergistic and cascaded combination therapy of different cancer types. STATEMENT OF SIGNIFICANCE: Targeting the tumor microenvironment (TME) to alter tumor metabolic pathways represents a promising strategy for next-generation cancer therapy. Herein, a copper-doped layered double hydroxide (LDH) nanoplatform is developed to co-deliver both diclofenac (DC) and lactate oxidase (LOX) to tumor cells for efficient dual regulation of tumor lactate and redox metabolisms, resulting in synergistic and cascaded chemodynamic therapy/immunotherapy of breast tumors. The developed LDH-DC-LOX nanoparticles can release Cu2+ and DC under an acidic TME, and can act in synergy to reduce TME lactate and generate H2O2, thus modulating redox metabolism and activating anticancer immunotherapy. The secreted cytokine IFN-γ after activation of antitumor immune responses can further mediate enhanced chemodynamic therapy effect through downregulation of cystine/glutamate transporter SLC7A11 to suppress GSH synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperHydroxidesImmunotherapyDrug Delivery SystemsAnimalsHumansFemaleMiceCell Line, TumorNanoparticlesDiclofenacMixed Function Oxygenases

Stichwörter der Autor:innen

Chemodynamic therapyImmunotherapyLactate metabolismLayered double hydroxideTumor microenvironment

Substanzen

CopperHydroxidesDiclofenaclactate 2-monooxygenaseMixed Function Oxygenases

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Fiber Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai…
  • Research Center for Analysis and Measurement, Donghua University, Shanghai 201620, China.
  • Institute of Frontier Medical Technology, College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • Fundação para a Ciência e a Tecnologia
  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Li, G., Wang, Z., Guo, Y., Ni, C., Gao, Y., Xu, K., Xiao, T., Shi, X., & Shen, M. (2025). Copper-doped layered double hydroxides co-deliver proteins/drugs for cascaded chemodynamic/immunotherapy via dual regulation of tumor metabolism. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.02.008

Vancouver

Li G, Wang Z, Guo Y, Ni C, Gao Y, Xu K, et al. Copper-doped layered double hydroxides co-deliver proteins/drugs for cascaded chemodynamic/immunotherapy via dual regulation of tumor metabolism. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.02.008

BibTeX
@article{Li2025,
  author = {Li, Gaoming and Wang, Zhiqiang and Guo, Yunqi and Ni, Cheng and Gao, Yue and Xu, Kaibing and Xiao, Tingting and Shi, Xiangyang and Shen, Mingwu},
  title = {Copper-doped layered double hydroxides co-deliver proteins/drugs for cascaded chemodynamic/immunotherapy via dual regulation of tumor metabolism},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2025.02.008}
}
Kostenlos starten →